Diagnostic criteria for Hypertension
hypertension diagnostic criteria classification blood pressure thresholds
hypertension staging ACC AHA JNC guidelines measurement
| Category | Office BP | HBPM | ABPM (Daytime) |
|---|---|---|---|
| Non-Elevated | SBP <120 and DBP <70 mmHg | SBP <120 and DBP <70 mmHg | SBP <120 and DBP <70 mmHg |
| Elevated BP | SBP 120–139 or DBP 70–89 mmHg | SBP 120–134 or DBP 70–84 mmHg | SBP 120–134 or DBP 70–84 mmHg |
| Hypertension | SBP ≥140 or DBP ≥90 mmHg | SBP ≥135 or DBP ≥85 mmHg | SBP ≥135 or DBP ≥85 mmHg |
| Category | SBP | DBP |
|---|---|---|
| Normal | <120 mmHg | <80 mmHg |
| Elevated | 120–129 mmHg | <80 mmHg |
| Stage 1 Hypertension | 130–139 mmHg | or 80–89 mmHg |
| Stage 2 Hypertension | ≥140 mmHg | or ≥90 mmHg |
| Hypertensive Crisis | >180 mmHg | and/or >120 mmHg |
Key difference: ACC/AHA 2017 defines hypertension at ≥130/80 mmHg, while ESC and most international guidelines retain the traditional ≥140/90 mmHg office threshold.
| Phenotype | Definition | Clinical Significance |
|---|---|---|
| White Coat Hypertension | Elevated office BP, normal HBPM/ABPM | Requires out-of-office confirmation before diagnosis |
| Masked Hypertension | Normal office BP, elevated HBPM/ABPM | Higher cardiovascular risk; detected by ABPM/HBPM |
| Isolated Systolic HTN | SBP ≥140, DBP <90 | Common in elderly; independent CV risk factor |
| Hypertensive Urgency | SBP >180 or DBP >120, no organ damage | Requires prompt but not emergency BP reduction |
| Hypertensive Emergency | Severely elevated BP + acute target organ damage | Requires ICU-level management |
Complications
hypertension complications target organ damage cardiovascular
hypertensive heart disease stroke renal failure complications
| Complication | Mechanism | Features |
|---|---|---|
| Left Ventricular Hypertrophy (LVH) | Chronic pressure overload → myocardial remodeling | Concentric or eccentric; detected on ECG/Echo |
| Heart Failure (HF) | LVH → diastolic dysfunction → systolic failure | HFpEF more common initially; HFrEF in late stages |
| Coronary Heart Disease (CHD) | Accelerated atherosclerosis | Angina, MI; HTN doubles CHD risk |
| Atrial Fibrillation | LA enlargement from elevated filling pressures | Major risk factor for cardioembolic stroke |
| Complication | Notes |
|---|---|
| Ischemic Stroke | Most common stroke type; HTN is the single greatest modifiable risk factor |
| Hemorrhagic Stroke | Due to rupture of small penetrating arteries (Charcot-Bouchard aneurysms) |
| Hypertensive Encephalopathy | Breakthrough hyperperfusion → cerebral edema; headache, confusion, seizures |
| Vascular Dementia | Chronic small vessel disease → lacunar infarcts, white matter changes |
| Lacunar Infarcts | Small deep infarcts from lipohyalinosis of perforating arteries |
| Complication | Mechanism |
|---|---|
| Hypertensive Nephrosclerosis | Afferent arteriolar sclerosis → ischemic glomerular injury → CKD |
| Proteinuria / Albuminuria | Early marker of glomerular damage; independent CV risk factor |
| Chronic Kidney Disease (CKD) | Reduced eGFR; HTN is a leading cause of end-stage renal disease (ESRD) |
| Renal Artery Stenosis | Can both cause and be worsened by hypertension (renovascular HTN) |
| Complication | Notes |
|---|---|
| Peripheral Arterial Disease (PAD) | Accelerated atherosclerosis in lower limb vessels; claudication, critical limb ischemia |
| Aortic Aneurysm | Especially thoracic and abdominal aortic aneurysms |
| Aortic Dissection | Acute HTN is the most common precipitant |
| Accelerated Atherosclerosis | Systemic endothelial injury across all vascular beds |
| Grade | Findings |
|---|---|
| I | Mild arteriolar narrowing, increased arteriovenous (AV) ratio |
| II | Definite arteriolar narrowing + AV nicking (Gunn's sign) |
| III | Flame hemorrhages, cotton wool spots, hard exudates |
| IV | Grade III + papilledema (hypertensive emergency) |
Hypertension
├── Heart → LVH, HF, CHD, AF
├── Brain → Stroke (ischemic/hemorrhagic), dementia, encephalopathy
├── Kidneys → CKD, proteinuria, ESRD
├── Vessels → PAD, aortic aneurysm, dissection
└── Eyes → Hypertensive retinopathy (Grades I–IV)
Hypertension doubles the risk of coronary heart disease, congestive heart failure, ischemic and hemorrhagic stroke, renal failure, and peripheral arterial disease. (Harrison's 21st ed., p. 7631)
Diagnostic methods
hypertension diagnostic methods investigation workup laboratory ECG
ambulatory blood pressure monitoring ABPM HBPM white coat hypertension diagnosis
hypertension evaluation secondary causes echocardiogram renal imaging workup
| ABPM Pattern | Definition | Significance |
|---|---|---|
| White Coat HTN | Elevated office BP, normal ABPM | Avoid unnecessary drug therapy |
| Masked HTN | Normal office BP, elevated ABPM | Higher CV risk; often undertreated |
| Sustained HTN | Elevated in both | Highest risk; treat promptly |
| Non-dipper | <10% nocturnal BP fall | Associated with increased organ damage |
| Test | Purpose |
|---|---|
| Urinalysis + urine albumin:creatinine ratio | Detect proteinuria/albuminuria (renal TOD) |
| Serum creatinine + eGFR | Renal function; detect CKD |
| Serum electrolytes (Na⁺, K⁺) | Hypokalemia → suspect primary aldosteronism |
| Fasting blood glucose / HbA1c | Diabetes co-assessment |
| Fasting lipid profile | Total CV risk stratification |
| Complete blood count (CBC) | Anemia, polycythemia |
| Thyroid function tests (TSH) | Hypothyroidism/hyperthyroidism as secondary cause |
| Serum uric acid | Gout risk; elevated in metabolic syndrome |
| Investigation | Indication |
|---|---|
| Renal ultrasound | Assess kidney size, echogenicity; detect renal artery stenosis |
| Renal Doppler ultrasound | Renovascular hypertension screening |
| MR/CT angiography | Confirm renal artery stenosis, aortic coarctation |
| Adrenal CT/MRI | Suspected pheochromocytoma or Conn's adenoma |
| Chest X-ray | Cardiomegaly, pulmonary congestion, aortic knuckle |
| Fundoscopy | Hypertensive retinopathy grading (KWB Grade I–IV) |
| Suspected Cause | Screening Test | Confirmatory Test |
|---|---|---|
| Primary Aldosteronism | Aldosterone:renin ratio (ARR) | Fludrocortisone suppression test; adrenal CT |
| Renovascular HTN | Renal Doppler ultrasound | CT/MR angiography |
| Pheochromocytoma | 24h urinary metanephrines or plasma metanephrines | Adrenal CT/MRI; MIBG scan |
| Cushing's Syndrome | 24h urinary cortisol; overnight dexamethasone suppression test | Low-dose DST; CRH stimulation test |
| Hypothyroidism / Hyperthyroidism | TSH | Free T4, T3 |
| Obstructive Sleep Apnea | Epworth sleepiness scale; SpO₂ monitoring | Polysomnography |
| Coarctation of Aorta | BP differential arms vs. legs; CXR (rib notching) | CT/MR aortography |
Elevated Office BP (≥140/90 mmHg)
↓
Confirm with ABPM or HBPM
↓
Routine labs + ECG + fundoscopy
↓
Assess target organ damage (Echo, renal function, urine albumin)
↓
Screen for secondary causes if clinically indicated
↓
Cardiovascular risk stratification → guide treatment threshold
Difference between hypertension and hypertonia
| Feature | Hypertension | Hypertonia |
|---|---|---|
| Definition | Persistently elevated blood pressure in the arterial system | Abnormally increased muscle tone (resistance to passive stretch) |
| System involved | Cardiovascular system | Neuromuscular system |
| Primary concern | Vascular/hemodynamic | Neurological/musculoskeletal |
| Measured by | Sphygmomanometer (mmHg) | Clinical examination (passive range of motion) |
| Type | Mechanism | Character | Associated Conditions |
|---|---|---|---|
| Spasticity | UMN lesion (corticospinal tract) | Velocity-dependent; "clasp-knife" phenomenon | Stroke, MS, cerebral palsy, spinal cord injury |
| Rigidity | Basal ganglia dysfunction | Velocity-independent; "lead-pipe" or "cogwheel" (with tremor) | Parkinson's disease, parkinsonian syndromes |
| Term | Meaning |
|---|---|
| Hypertension | High blood pressure |
| Hypertonia | High muscle tone |
| Hypertrophy | Increase in cell/organ size |
| Hypertonicity | High osmolarity of a solution (also used loosely for hypertonia) |